The Evidence for Rapamycin: Can a Transplant Drug Extend Human Healthspan?
Decades of animal data show rapamycin is the most potent life-extending drug ever tested. Now, a wave of human clinical trials is revealing what it actually does to the aging human body.
By Factlen Editorial Team
Geroscience Researchers 40%Longevity Clinicians 35%Regulatory Skeptics 25%
- Geroscience Researchers
- Scientists prioritizing rigorous clinical trials to validate biomarkers and precise dosing before widespread use.
- Longevity Clinicians
- Physicians who believe the current safety data justifies off-label prescribing to improve patient healthspan today.
- Regulatory Skeptics
- Critics who emphasize the lack of FDA approval and the unknown long-term risks of altering fundamental growth pathways.
What's not represented
- · Long-term off-label users who have self-experimented with rapamycin for over a decade.
- · Health insurance providers evaluating the cost-benefit of preventative gerotherapeutics.
Why this matters
Aging is the primary risk factor for cancer, heart disease, and neurodegeneration. If drugs like rapamycin can safely slow the biological aging process, the focus of medicine could shift from treating individual diseases to preserving overall cellular health.
More in health
See all 109 stories →Lupus Treatment
A Cancer Therapy is 'Resetting' the Immune System to Send Severe Lupus into Remission
9 sources
Longevity Science
Rapamycin and Longevity: What the Latest Human Trials Actually Show
8 sources
Depression Treatment
Massive Data Reviews Confirm Exercise Matches Medication and Therapy for Depression
7 sources
Autoimmune Breakthrough
How an 'Immune Reset' Therapy is Putting Severe Lupus into Remission
6 sources
Stay informed
Every angle. Every day.
Get health stories with full source coverage and perspective breakdowns delivered to your inbox.